Amphenol Corporation
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-78.8% vs price
Base Case (Median)
-62.4% vs price
Bull Case (75th pct.)
-45.6% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $22.94 | -84.8% | High (40%) |
| PE Comparable | $87.65 | -41.8% | Medium (25%) |
| Growth Trajectory DCF | $167.42 | 11.2% | Medium (20%) |
| Graham Number | $29.36 | -80.5% | Low (10%) |
| EV/EBITDA | $56.57 | -62.4% | Medium (20%) |
| EV/FCF | $76.04 | -49.5% | Medium (20%) |
| Earnings Power Value | $34.47 | -77.1% | Medium (50%) |
Based on 7 out of 8 methods, APH appears overvalued at the current price of $150.51. The base case fair value of $56.57 implies 62.4% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.